Table 1.
Characteristica | Subcohort (15% sample weight 6.67) N=771 | Cases (Breast Cancer Deaths) N=449 | ||
---|---|---|---|---|
N | % | N | % | |
Age Group | ||||
<40 | 49 | 7.1 | 53 | 11.8 |
40–49 | 166 | 23.9 | 132 | 29.4 |
50–59 | 249 | 35.8 | 159 | 35.4 |
60–69 | 231 | 33.2 | 105 | 23.4 |
Ethnicity | ||||
Hispanic | 176 | 25.3 | 156 | 34.7 |
Non-Hispanic | 519 | 74.7 | 293 | 65.3 |
Year of Diagnosis | ||||
1997–2000 | 206 | 29.6 | 190 | 42.3 |
2001–2004 | 197 | 28.3 | 144 | 32.1 |
2005–2009 | 292 | 42.0 | 115 | 25.6 |
Tumor Sizeb | ||||
≤ 1.0 cm | 160 | 24.5 | 27 | 6.4 |
>1–3 cm | 356 | 54.6 | 204 | 48.5 |
>3–5 cm | 72 | 11.1 | 85 | 20.1 |
>5 cm | 32 | 4.9 | 40 | 9.5 |
Chest wall/Skin | 32 | 4.9 | 65 | 15.4 |
Missing | 42 | 28 | ||
Number of Positive Nodes | ||||
0 | 454 | 66.6 | 151 | 34.6 |
1–3 | 159 | 23.4 | 165 | 37.8 |
≥4 | 68 | 10.0 | 121 | 27.6 |
Missing | 14 | 12 | ||
Tumor Grade | ||||
Grade I | 182 | 28.1 | 37 | 8.9 |
Grade II | 257 | 39.7 | 129 | 31.0 |
Grade III/IV | 208 | 32.1 | 250 | 60.1 |
Missing | 48 | 33 | ||
Estrogen Receptor | ||||
Positive | 553 | 82.4 | 297 | 68.6 |
Negative | 118 | 17.6 | 136 | 31.4 |
Missing | 24 | 16 | ||
Progesterone Receptor | ||||
Positive | 469 | 72.8 | 226 | 54.3 |
Negative | 175 | 27.2 | 190 | 45.7 |
missing | 51 | 33 | ||
Her2/neu | ||||
Positive | 94 | 16.6 | 53 | 23.8 |
Negative | 471 | 83.3 | 170 | 76.2 |
missing | 130 | 38 |
Tumor characteristics, including estrogen receptor positivity, are influenced by the study restriction to stages I–III and a minimum of 12 months survival.
Tumor size categorized to facilitate assessment according to National Comprehensive Cancer Network cut points (Figure 2). Note that most women with missing values had American Joint Commission on Cancer (AJCC) tumor size = T2 (2–5 cm) but actual size unknown; thus, they could not be assigned to the ≤ 3 cm or > 3 cm categories.